ID: 3520219 A RANDOMIZED TRIAL OF AGGRESSIVE FLUID HYDRATION TO PREVENT POST-ERCP PANCREATITIS (FLUYT)

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal anti-inflammatory drugs (NSAID) reduce post-ERCP pancreatitis rates and are current standard-of-care as per European and American guidelines. A number of studies suggest that aggressive periprocedural hydration is effective and safe in reducing post-ERCP pancreatitis. However, patients in these studies did not receive...